IDEX Corporation released second quarter and first half 2026 results and updated its share repurchase program, with the stock trading at US$230.45 and up 28.7% year to date. The most followed narrative on Simply Wall St places fair value at US$248 per share, suggesting the stock is 7.1% undervalued, driven by international expansion and technology adaptation in markets like pharmaceuticals and data centers. However, the current price-to-earnings ratio of 32.7x exceeds the fair ratio of 27.1x and the US Machinery industry average of 27.3x, indicating investors are already paying a premium. Bulls point to growing sales, earnings, and the buyback as signs of further upside, while bears highlight the higher starting price and risks including tariff-related cost pressure and softer demand in semiconductors and agriculture.
IDEX CorporationEarnings and buyback fuel valuation debate; stock up 28.7% YTD but P/E premium and tariff/semiconductor risks create mixed outlook.